4//SEC Filing
Kiaie Namvar 4
Accession 0001213900-20-031362
CIK 0001726711other
Filed
Oct 14, 8:00 PM ET
Accepted
Oct 15, 6:11 AM ET
Size
5.4 KB
Accession
0001213900-20-031362
Insider Transaction Report
Form 4
Kiaie Namvar
Director
Transactions
- Disposition to Issuer
Stock Option (Right to Buy)
2020-10-13−10,000→ 10,000 totalExercise: $1.94Exp: 2030-10-13→ Common Stock (10,000 underlying)
Footnotes (1)
- [F1]25% of the stock options vest immediately, and the remaining 75% of the stock options will vest in three equal quarterly installments on the last day of each subsequent fiscal quarter, beginning December 31, 2020.
Documents
Issuer
ADiTx Therapeutics, Inc.
CIK 0001726711
Entity typeother
Related Parties
1- filerCIK 0001817639
Filing Metadata
- Form type
- 4
- Filed
- Oct 14, 8:00 PM ET
- Accepted
- Oct 15, 6:11 AM ET
- Size
- 5.4 KB